6-(trifluoromethyl)pyridine-2-carboxylic acid (also named as 6-(trifluoromethyl)picolinic acid)is a useful trifluoromethylated building block for the preparation of various compounds of interest in pharmaceuticals and agrochemicals.
A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin. 
SAR studies of non-zinc-chelating MMP-13 inhibitors: Improving selectivity and metabolic stability. 
From Lead to Drug Candidate: Optimization of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer.
Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs).